Lifevantage Corporation
Research Lifevantage Corporation (LFVN) on Bullrun: market cap USD 86.29M, P/E 15.4, dividend yield 3.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLFVN
- ExchangeNASDAQ
- CountryUnited States
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyUSD
- Market capUSD 86.29M
- P/E15.4
- Dividend yield3.0%
- Financial periodQ1 2026
- RevenueUSD 43.72M
- Net incomeUSD 1.36M
- Free cash flowUSD 3.78M
- Gross margin349.1%
Valuation Snapshot
latest market cap is USD 86.29M; P/E is 15.4; dividend yield is 3.0%.
Peer valuation comparison
Latest P/E is 15.37x versus a Consumer Defensive sector median of 17.41x (11.7% below).
Latest dividend yield is 2.95% versus a Consumer Defensive sector median of 3.04% (3.0% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 228.53M | USD 9.81M | USD 10.51M | 80.4% | 0.75 | USD 20.20M | USD 10.69M | USD 34.64M |
| FY2024 | USD 200.16M | USD 2.94M | USD 9.95M | 79.3% | 0.23 | USD 16.89M | USD 12.77M | USD 25.99M |
| FY2023 | USD 213.40M | USD 2.54M | USD 3.76M | 79.7% | 0.2 | USD 21.61M | USD 13.78M | USD 34.65M |
| FY2022 | USD 206.36M | USD 3.12M | USD 6.43M | 81.5% | 0.24 | USD 20.19M | USD 15.76M | USD 31.52M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 86.29M | 15.4 | 2.8% | 0.19 |
| 2025 | 2025-12-31 | USD 78.77M | 10.3 | 3.1% | 0.19 |
| 2024 | 2024-12-31 | USD 220.00M | 30.8 | 0.9% | 0.16 |
| 2023 | 2023-12-29 | USD 76.28M | 30.0 | 9.2% | 0.55 |
| 2022 | 2022-12-30 | USD 46.72M | 124.0 | 2.4% | 0.09 |
| 2021 | 2021-12-31 | USD 81.17M | 8.7 | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.19 USD, yield 3.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.17 USD |
| FY2024 | 0.55 USD |
| FY2023 | 0.13 USD |
| FY2022 | 0.03 USD |
About Lifevantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health;
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Lifevantage Corporation's market cap?
Lifevantage Corporation's market capitalization is USD 86.29M.
What is Lifevantage Corporation's P/E ratio?
Lifevantage Corporation's price-to-earnings (P/E) ratio is 15.4.
Does Lifevantage Corporation pay a dividend?
Lifevantage Corporation has a dividend yield of 3.0%.
What does Lifevantage Corporation do?
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally.